Bioinformatic reanalysis of public proteomics data reveals that nuclear proteins are recurrent in cancer secretomes

Autor(es)

De Morais, Juliana A. ^[1] ; Zelanis, Andre ^[1]

Afiliação do(s) autor(es)

^[1] Univ Fed Sao Paulo, UNIFESP, Inst Sci & Technol, Funct Prote Lab, Sao Jose Dos Campos, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: TRAFFIC; v. 23, n. 2 DEC 2021.
• Citações Web of Science: 0

Resumo

Proteins secreted by tumoral cells (cancer secretomes) have been continuously associated with cancer development and progression processes. In this context, secreted proteins contribute to the signaling mechanisms related to tumor growth and spreading and studies on tumor secretomes provide valuable clues on putative tumor biomarkers. Although the in vitro identification of intracellular proteins in cancer secretome studies has usually been associated with contamination derived from cell lysis or fetal bovine serum, accumulated evidence reports on intracellular proteins with moonlighting functions in the extracellular environment. In this study, we performed a systematic reanalysis of public proteomics data regarding different cancer secretomes, aiming to identify intracellular proteins potentially secreted by tumor cells via unconventional secretion pathways. We found a similar repertoire of unconventionally secreted proteins, including the recurrent identification of nuclear proteins secreted by different cancer cells. In addition, in some cancer types, immunohistochemical data were in line with proteomics identifications and suggested that nuclear proteins might relocate from the nucleus to the cytoplasm. Both the presence of nuclear proteins and the likely unconventional secretion of such proteins may comprise biological signatures of malignant transformation in distinct cancer types and may be targeted for further analysis aiming at the prognostic/therapeutic value of such features. (AU)

• Processo FAPESP: 19/07282-8 - Prospecção de marcadores associados a processamento proteolítico em amostras de plasma de pacientes com melanoma
• Beneficiário: André Zelanis Palitot Pereira
• Linha de fomento: Auxílio à Pesquisa - Regular
• Processo FAPESP: 14/06579-3 - Análise sistêmica do processamento N-terminal e diversidade de proteínas no secretoma de células tumorais
• Beneficiário: André Zelanis Palitot Pereira
• Linha de fomento: Auxílio à Pesquisa - Jovens Pesquisadores